News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,596 Results
Type
Article (14236)
Company Profile (281)
Press Release (253079)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79522)
Career Advice (153)
Deals (13227)
Drug Delivery (35)
Drug Development (50457)
Employer Resources (31)
FDA (5721)
Job Trends (5132)
News (144420)
Policy (10031)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21667)
ALS (63)
Alzheimer's disease (845)
Antibody-drug conjugate (ADC) (96)
Approvals (5744)
Artificial intelligence (121)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (49)
Brain cancer (20)
Breast cancer (150)
Cancer (1406)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (112)
Cell therapy (317)
Cervical cancer (8)
Clinical research (41027)
Collaboration (533)
Compensation (256)
Complete response letters (13)
COVID-19 (1034)
CRISPR (39)
C-suite (158)
Cystic fibrosis (76)
Data (1449)
Denatured (11)
Depression (29)
Diabetes (133)
Diagnostics (1296)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (84)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (29762)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48399)
Executive appointments (449)
FDA (6395)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (495)
Gene editing (93)
Generative AI (10)
Gene therapy (241)
GLP-1 (364)
Government (1078)
Grass and pollen (2)
Guidances (19)
Healthcare (6593)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (89)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (64)
Interviews (17)
IPO (7269)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (206)
Leadership (3)
Legal (1386)
Liver cancer (31)
Lung cancer (200)
Lymphoma (96)
Machine learning (2)
Management (7)
Manufacturing (134)
MASH (51)
Medical device (2597)
Medtech (2598)
Mergers & acquisitions (6280)
Metabolic disorders (381)
Multiple sclerosis (52)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (25)
Neuroscience (1240)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1656)
Now hiring (22)
Obesity (192)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (54)
Parkinson's disease (119)
Partnered (8)
Patents (125)
Patient recruitment (73)
Peanut (35)
People (25614)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14486)
Phase II (19088)
Phase III (12068)
Pipeline (780)
Policy (44)
Postmarket research (852)
Preclinical (6087)
Press Release (30)
Prostate cancer (59)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (287)
Real estate (1418)
Recruiting (12)
Regulatory (8609)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (58)
Series A (97)
Series B (62)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1447)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1974)
State (1)
Stomach cancer (4)
Supply chain (22)
Tariffs (6)
The Weekly (36)
United States (12889)
Vaccines (208)
Venture capitalists (32)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (106)
Last 7 days (309)
Last 30 days (1454)
Last 365 days (19504)
2025 (5775)
2024 (20551)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17280)
Australia (2931)
California (3753)
Canada (1115)
China (343)
Colorado (145)
Connecticut (149)
Delaware (96)
Europe (37172)
Florida (452)
Georgia (115)
Idaho (16)
Illinois (225)
India (10)
Indiana (91)
Iowa (1)
Japan (73)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (464)
Massachusetts (2971)
Michigan (70)
Minnesota (144)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (940)
New Mexico (12)
New York (1014)
North Carolina (542)
North Dakota (4)
Northern California (1656)
Ohio (111)
Oklahoma (9)
Oregon (21)
Pennsylvania (714)
Puerto Rico (5)
Rhode Island (18)
South America (208)
South Carolina (4)
Southern California (1447)
Tennessee (25)
Texas (436)
Utah (50)
Virginia (76)
Washington D.C. (30)
Washington State (343)
Wisconsin (14)
267,596 Results for "zevra therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Zevra Therapeutics Files Preliminary Proxy
April 1, 2025
·
10 min read
Press Releases
Zevra Therapeutics to Present at the 21st Annual WORLDSymposium™
January 30, 2025
·
11 min read
Press Releases
Zevra Announces Publication of MIPLYFFA® Mechanism of Action Manuscript in Molecular Genetics and Metabolism
April 17, 2025
·
8 min read
Press Releases
Zevra Therapeutics to Participate at Upcoming February 2025 Investor Conferences
January 30, 2025
·
2 min read
Press Releases
Zevra Therapeutics Announces Organizational Changes
December 9, 2024
·
4 min read
Business
Zevra Therapeutics Expands Executive Leadership Team
Zevra Therapeutics, Inc. today announced the appointments of Rahsaan W. Thompson as Chief Legal Officer, Secretary and Compliance Officer, and Alison Peters as Chief People Officer.
June 25, 2024
·
7 min read
Press Releases
Zevra Therapeutics Enters Agreement to Sell its Rare Pediatric Disease Priority Review Voucher for $150 Million
February 27, 2025
·
3 min read
Press Releases
Zevra Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $150 Million
April 7, 2025
·
4 min read
Press Releases
Zevra to Participate at Upcoming March 2025 Investor Conferences
February 25, 2025
·
2 min read
Adcomms
FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
The Genetic Metabolic Diseases Advisory Committee will meet on Friday to discuss Zevra’s modified scale to describe the efficacy of its drug candidate for the treatment of Niemann-Pick disease type C.
August 1, 2024
·
2 min read
·
Tristan Manalac
1 of 26,760
Next
